June 2008
·
16 Reads
·
13 Citations
Journal of Cardiovascular Electrophysiology
This page lists works of an author who doesn't have a ResearchGate profile or hasn't added the works to their profile yet. It is automatically generated from public (personal) data to further our legitimate goal of comprehensive and accurate scientific recordkeeping. If you are this author and want this page removed, please let us know.
June 2008
·
16 Reads
·
13 Citations
Journal of Cardiovascular Electrophysiology
October 2007
·
56 Reads
·
11 Citations
Pacing and Clinical Electrophysiology
FURMAN, S., ET AL.: Survival of Implantable Pacemaker Leads. Early polyurethane leads were reported to have a high incidence of materials failure. In 1979 a six-center registry was begun. By October 31, 1989, 7, 311 leads had been registered and lead longevity was calculated by individual manufacturer, cumulatively for all manufacturers and for individual leads. Each lead was registered at implant and at removal from service as having been removed for materials failure or for unrelated reasons. Calculations were made for 23 models and for a total of three manufacturers with more than 100 leads implanted. Four thousand seven hundred and sixty three leads (65.1%) were from Medtronic; 2, 177 (29.8%) from Cordis; 297 (4.1%) from Intermedics; and 77 (1.0%) were from all others. The 10-year cumulative survival of Medtronic leads was 96.6 ± 0.4%; for Cordis leads it was 99.9 ± 0.1% and for Intermedics leads 97.7 ± 0.9%. Three lead models registered over 100 units and had poorer survival at 5 years than the remainder of all manufacturers' experience. They were #6972 (n = 107) with 78.6 ± 4.5%; #6991U (n = 294) with 90.6 ± 1.9%; and #4012 (n = 288) with 97.3 ± 1.5%. Other possibly failed models did not achieve statistical significance. It can be anticipated that a lead which survives to the seventh year will have prolonged longevity as thereafter additional failures are uncommon.
December 2006
·
8 Reads
·
7 Citations
December 2006
·
6 Reads
June 2006
·
35 Reads
·
2 Citations
Pacing and Clinical Electrophysiology
Four commerciaily available fransvenous pacing leads were evaluated in a series of 240 implanfs on a rotalional order basis. Total (in-tra- and post-operative) failure rates for this series were: Cordis 1 mm, 1/60 (1.7%); Biotroniik IE-65-I, 5/60 (8.3%); Medtronic 6961, 4/60 (6.7%); and CP1 4316, 6/60 (10.0%). Post-operative faiJure rates were: l mm, 1/60 (1.7%); IE-65-1, 4/59 (6.8%); 6961, 0/56 (0.0%), and 4116, 3/57 (5.3%). In a previous study conducted at this center with identical protocol, total failure rates were: Medtronic 6907, 7/76 (9.2%); Cordis CL, 7/76 (9.2%); Biotronik IE-65-I, 2/76 (2.6%); and the Vitatron MIP-2000, 9/45 (20.0%). Post-operotive failure rates were: 6907, 4/73 (5.5%); CL, 6/75 (8.0%); IE-65-I, 2/76 (2.6%); and MIP-2000, 5/41 (12.2%). If the two IE-65-1 series are combined, the totaJ faiJure rate is 7/136 (5.1 %), and the post-operative failure rate is 6/135 (4.4%). Significant differences exist between the highest and lowest failure rates in total and post-operative cases for each series. The final decision concerning use of a par-ticular lead must, of course, be based on clinical criteria.
June 2006
·
10 Reads
·
15 Citations
Pacing and Clinical Electrophysiology
Loss of normal pacemaker stimulation and for sensing functions requires prompt detection, automatic correction, and automatic and continuous “marking” of the intermittent failure, The autodiugnostic pacemaker (ADP) detects “failure to capture” (FC) by distinguishing, at its single stimulating and sensing electrode, between the normal biphasic cardiac response evoked by an adequate stimulus (corresponding to the QRS and T waves on the surface cardiogram) and the monophasic pseudo-response generated by electrolonic spread of a subthreshold stimulating current. Detection of “failure to sense” (FS) spontaneous cardiac activity requires two amplifiers: a “timing control” amplifier of standard fidelity and standard (approximately 250 ms) refractory period, and a second amplifier which has negligible refractoriness and provides high fidelity amplification of all evoked and spontaneous activity. Failure to sense (FS) is defined as a specified number of consecutive failures to recycle correctly (he pacemaker's timing circuits. Similarly, a specified number of consecutive failures of the stimulus to evoke an active cardiac response is defined as a failure to capture (FC). When FC is detected, the ADP doubles the applied stimulus voltage and generates marker pulses which follow every subsequent stimulus by 40 ms. The marker pulses appear on the surface electrocardiogram, serving as an externally detectable “memory” of the earlier, possibly corrected, failure. When FS is detected, non-stimulating marker pulses, of a difficult time relation (80 ms delay) to each stimulus, are generated continually and can also be detected externally. The ADP has been tested in 14 anesthetized, open-chest dogs. Unipolar rather than bipolar electrodes were used as they provided more reliable stimulation and more satisfactory electrograms for detection.
June 2006
·
43 Reads
·
15 Citations
Pacing and Clinical Electrophysiology
June 2006
·
64 Reads
·
14 Citations
Pacing and Clinical Electrophysiology
June 2006
·
13 Reads
·
9 Citations
Pacing and Clinical Electrophysiology
June 2006
·
24 Reads
Pacing and Clinical Electrophysiology
... It is therefore not surprising that apical RV pacing is pathologic and imposes acute and chronic adverse effects on ventricular hemodynamics, function, myocardial perfusion, and cellular structure [2,3]. These experimental data are validated by the above mentioned clinical observations that chronic ventricular pacing in both the VVI/VVIR and the DDDR modes causes autonomic dysfunction [35,36], increased left heart size and reduced LV function compared with normal heart activation and atrial pacing which presumably explains the adverse outcomes in the clinical trials cited previously. Ventricular desynchronization itself may also cause severe mitral regurgitation that may precipitate AF and CHF [37,38]. ...
Reference:
The quest for physiological pacing
July 1994
American Journal of Noninvasive Cardiology
... The AIDs were relatively bulky (over 290 grams and a volume of over 150 ml), placed subcutaneously in the abdominal region and needed a median sternotomy/left lateral thoracotomy to fix the two patch electrodes on the epicardial surface; features such as pacing or other adjustable functions were unavailable at the time [3]. The second generation systems (AID-B) had bradycardia pacing and minimal programmability and the third generation systems, introduced in the early 1990s had antitachycardia pacing (ATP), low energy shocks for ventricular tachycardia (VT) treatment, extensive programmability and telemetry [4]. Since 1988 thoracotomy became unnecessary and the pacing lead system was placed transvenously [5], monophasic waves were no longer satisfactory for the transvenous approach, and which benefited the development of biphasic waveforms in 1991. ...
December 1992
Journal of Cardiovascular Electrophysiology
... The initial indications for ICD usage emerged largely from expert consensus documents, but have now been replaced by evidence-based practice guidelines, which, in significant part, are based on these trial data, and have seriously expanded ICD indications [3,4]. Despite apparently robust clinical trial evidence, clinical usage patterns and therapeutic benefits have been repeatedly questioned [5]. ...
September 1991
... [Zehender M et al., 1992;Zehender M et al., 1994]. [Bohm A et al., 2000;Tegtmeyer CJ et al., 1981;Vijayaraman P et al., 2002;Wallace WA et al., 1970] oder durch Defekte der Elektrode bedingt sein [Alonso C et al., 2001;Glikson M et al., 1994a;Glikson M et al., 1994b;Kawanishi DT et al., 1996;Kazama S et al., 1993;Ohm OJ, 1980;Parsonnet V et al., 1981]. Als Schrittmacher-Twiddler-Syndrom wird die ineffektive Impulsgabe durch den Herzschrittmacher bezeichnet, wenn diese durch multifaktorielle Rotation des Aggregates oder Isolationsschäden an der Elektrode aufgrund von Knickbildungen oder Längstorsion bedingt ist [Ellringmann U et al., 1977;Gialafos J et al., 1995;Lal RB et al., 1990;Young KR et al., 2002]. ...
November 1996
Pacing and Clinical Electrophysiology
... [1][2][3][4] Despite this, there are medical indications for ICD deactivation/explantation that include remission of cardiac arrhythmia, infection, lead failure, and heart transplant. 5 Furthermore, as the rate of ICD implantation increases and patients with ICDs approach the end of their lives, it is likely that clinicians will receive an increasing number of requests to discontinue ICD support. Clinicians may also receive such requests due to impaired quality of life (QOL) associated with ICD shocks. ...
January 1993
Pacing and Clinical Electrophysiology
... Various studies show infection rates of CEIDs between 1% and 7%. Likewise, the rate of dysfunctional leads reaches 7% [3][4][5][6][7]. The gold standard for treating CIED infection is device explanation as there is no therapy successful enough to eradicate the infection [8,9]. ...
April 2000
Pacing and Clinical Electrophysiology
... A specific HRV analysis is executed with the aid of KUBIOS software developed by the Biosignal Analysis and Medical Imaging Group of the University of Eastern Finland. KUBIOS analysis is based on the heart rate variability guidelines (Malik, 1996). After filtering outliers in the RR time trace, a spectral analysis is executed. ...
June 2006
Pacing and Clinical Electrophysiology
... The choice between a unipolar and a bipolar pacing lead system is an old dilemma that has so far remained unresolved. Although some doubts can be expressed concerning the reliability of bipolar lead models [1] [2] , the advantages of these types of leads are evident in clinical practice, in particular because of the absence of extracardiac interference including that from skeletal muscle. But there are also differences between unipolar and bipolar electrodes from the point of view of electrical performance, in terms of pacing threshold, sensing and energy consumption [3] [4] [5] [6] . ...
October 2007
Pacing and Clinical Electrophysiology
... We found predominance of the sympatho-excitatory effect of adenosine [17] that overrides cardiac inhibition comparable to patients without SND resulting in a significant increase in HR. We selected DOO pacing only in patients with sinusbradycardia <45 bpm to prevent competitive atrial stimulation which can induce AF [18], also considering the fact that adenosine may promote AF by shortening the atrial action potential and refractory period [19]. Avoiding competitive atrial stimulation by pacing above intrinsic HR is not useful due to the acceleration of HR under adenosine (up to 40 bpm in tis study). ...
June 2006
Pacing and Clinical Electrophysiology
... For all studies, we set the "active mode" length to 1 ms. This stimulation duration is considered to be in the upper range for an effective pulse width as a result of the leveling effect of the strength-duration curve [35]. At 60 beats per minutes (BPM), this 1 ms "active mode" would be separated by intervals of 999 ms in "idle mode." ...
June 2008
Journal of Cardiovascular Electrophysiology